Radius R L
Arch Ophthalmol. 1983 Jun;101(6):898-900. doi: 10.1001/archopht.1983.01040010898008.
Forty eyes in 20 patients with elevated intraocular pressure were treated with either a 0.125% betaxolol ophthalmic solution or a placebo. After 2, 4, and 6 weeks of twice-daily therapy, the eyes receiving the betaxolol had a mean percent reduction in IOP greater than that in the eyes treated only with the drug vehicle (placebo). Both solutions were well tolerated.
对20例眼压升高患者的40只眼睛,分别用0.125%倍他洛尔眼药水或安慰剂进行治疗。经过每日两次治疗2周、4周和6周后,接受倍他洛尔治疗的眼睛眼压平均降低百分比高于仅用药物溶媒(安慰剂)治疗的眼睛。两种溶液耐受性均良好。